-17.95 (-1.09%) The Exchange has sought clarification from Sun Pharmaceutical Industries on February 16, 2017, with reference to news appeared in CNBC TV 18 dated February 16, 2017 ‘UK Regulator approves Sun Pharma Generic drug of Tobramycin.’
The above information is a part of company’s filings submitted to BSE.